Restructuring and Other Items

3 Months Ended

Mar. 31, 2012

Restructuring and Other Items [Abstract]

Note 2: Restructuring and Other Items

Restructuring and other items consisted of:

	Three Months Ended
	March 31,
($ in millions)	2012			2011
Restructuring and related charges:
Severance and post-employment benefits	$	-		$	1.5
Impairments and asset write-offs		0.2			0.2
Other restructuring charges		0.2			0.2
Total restructuring and related charges		0.4			1.9

Acquisition-related contingencies		0.2			-
Foreign exchange and other		(0.8	)		(0.2	)
Total restructuring and other items	$	(0.2	)	$	1.7

Restructuring and Related Charges

During the three months ended March 31, 2012 and 2011, we incurred restructuring and related charges of $0.4 million and $1.9 million, respectively, associated with the restructuring plan announced in December 2010. Charges incurred under this plan consist of costs associated with the 2011 closure of a plant in the United States and a reduction of operations at a manufacturing facility in England. We currently expect to incur additional charges related to the plan of approximately $1.6 million during the remainder of 2012, which consist of approximately $1.2 million in cash expenditures for severance and costs associated with the plant closure and fixed asset relocation, and approximately $0.4 million in non-cash asset impairment and disposal charges.

The following table presents activity related to our restructuring obligations:

($ in millions)	Severance and benefits			Other Costs			Total
Balance, December 31, 2011	$	6.2		$	0.6		$	6.8
Charges		-			0.4			0.4
Cash payments		(0.9	)		(0.4	)		(1.3	)
Non-cash adjustment		-			(0.2	)		(0.2	)
Balance, March 31, 2012	$	5.3		$	0.4		$	5.7

Other Items

The liability for contingent consideration related to our 2010 acquisition of technology used in our SmartDose™ electronic patch injector system increased by $0.2 million during the three months ended March 31, 2012, due to accretion expense.